Xlife Sciences AG (XLS) — Cash Flow Reinvestment Rate
Latest as of December 2023:
0.24x
Xlife Sciences AG (XLS) has a Cash Flow Reinvestment Rate of 0.24x as of December 2023, reinvesting CHF41.08K (capex CHF41.08K ) from operating cash flow of CHF171.78K. Explore XLS capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.24x
(Capex + Investments) / Operating CF
Total Reinvested
CHF41.08K
Capex + Investments
Operating Cash Flow
CHF171.78K
CHF
Capital Expenditures
CHF41.08K
CHF
Xlife Sciences AG Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Xlife Sciences AG across 1 annual periods. Also explore XLS current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xlife Sciences AG (2023–2023)
Year-by-year capital reinvestment analysis for Xlife Sciences AG. For live market cap and broader valuation context, see market cap of Xlife Sciences AG.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 6.14x | CHF1.06 Million | CHF171.78K | CHF41.08K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow